文档介绍：第 卷第 期 华 夏 医 学
34 4 疗 效果显著,能改善体力功能状况,降低血清肿瘤标志物,安全性高。
ES-SCLC
关键词: 阿替利珠单抗; 方案;广泛期小细胞肺癌
EP
中图分类号: 文献标志码: 文章编号: ( )
A 1008-2409 2021 04-0023-04
Efficacy of atirizumab combined with etoposide and cisplatin regimen in patients with extensive
stage small cell lung cancer / JIN Jing① Dept. of Oncology the Oilfield General Hospital of
∥ ,
Puyang Puyang 457000 China
, ,
Abstract
Objective: To investigate the effects of atirizumab combined with etoposide and cisplatin(EP)
regimen in patients with extensive stage small cell lung cancer. Methods: 98 patients with extensive stage
small cell lung cancer(ES-SCLC) were randomized into 2 groups, each with 49 cases. The control group
were treated with EP regimen, while the observation group adopted atirizumab combined with EP regimen.
Then, the clinical efficacy, KPS score before treatment and 4 weeks after treatment, serum tumor marker
levels(CA 125, CA199 and CEA), ratio of adverse reactions and pharmaco